Global 3D Cell Culture Market Research Report 2022

A 3D cell culture is an artificially-created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Unlike 2D environments (e.g. a petri dish), a 3D cell culture allows cells in vitro to grow in all directions, similar to how they would in vivo. These three-dimensional cultures are usually grown in bioreactors, small capsules in which the cells can grow into spheroids, or 3D cell colonies. Approximately 300 spheroids are usually cultured per bioreactor.
The 3D Cell Culture industry can be broken down into several segments, Scaffold-based, Scaffold-free, Microchips, etc.
Across the world, the major players cover Thermo Fisher Scientific, Corning, Greiner Bio-One, Merck, Lonza Group, Emulate, TissUse, CN Bio, TARA Biosystems, Mimetas, Nortis, etc.
Due to the COVID-19 pandemic, the global 3D Cell Culture market size is estimated to be worth US$ 407.3 million in 2021 and is forecast to a readjusted size of US$ 918.9 million by 2028 with a CAGR of 12.3% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe 3D Cell Culture market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe 3D Cell Culture landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Global core 3D cell culture manufacturers include Thermo Fisher Scientific, Corning, Merck etc.The top 3 companies hold a share about 60%.North America is the largest market, with a share about 40%, followed by Europe and Asia Pacific with the share about 30% and 20%.In terms of product, scaffold-based is the largest segment, with a share over 60%. And in terms of application, the largest application is efficacy vs. toxicology testing, followed by leading models.
This report focuses on 3D Cell Culture volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall 3D Cell Culture market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global 3D Cell Culture Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Scaffold-based
Scaffold-free
Microchips
Segment by Application
Efficacy vs. Toxicology Testing
Leading Models
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Thermo Fisher Scientific
Corning
Merck
Greiner Bio-One
Lonza Group
Emulate
TissUse
CN Bio
TARA Biosystems
Mimetas
Nortis
Reprocell Incorporated
Jet Bio-Filtration
InSphero AG
3D Biotek

Frequently Asked Questions